SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
- by Lorene Schwartz
- in People
- — Jan 4, 2021
"Therefore, Covishield is safe and can be used effectively for prevention of COVID-19 in the targeted population", the EUA application signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII), had stated.
The trial included data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry said in a statement.
"Congress and the Opposition is not proud of anything Indian".
We have always said that we will keep giving 50% of everything we make to India and to Covax at the same time.
Veteran US talk show host Larry King has been hospitalised with Covid-19.
Germany's Robert Koch Institute said Sunday that 238,809 people have been vaccinated there - a far cry from neighbouring France, where the government has come under pressure over a slow rollout.
Crowds throng at the Taj Mahal over the weekend as India fights rising coronavirus infections.
Footballers were also among those caught breaking the rules, with Tottenham's Erik Lamela, Sergio Reguilon and Giovani Lo Celso to be disciplined after a picture emerged of them attending a large party.
New Delhi
Jairam Ramesh retorted, "So says the in-house Goebbels-cum-Albert Speer".
Tharoor, a Congress MP and former union minister, also countered Puri, saying he had never questioned the valour of our soldiers.
Meanwhile, Guleria asserted that the vaccines being developed in India are safe and praised them, suggesting that they are cost-effective and easy to administer, as they can be stored in temperatures between 2 to 8 degrees Celsius, reported ANI. Short-circuiting the process is unprecedented, inadvisable & risks lives.
"The hypothesis being propagated that the whole virion inactivated vaccine is likely to be effective against mutations of the virus is not being supported by any efficacy from the trial because no data have as yet been generated in the Phase 3 trial".
"Approval was premature and could be unsafe", said opposition lawmaker and former minister Shashi Tharoor. Phase 3 trials for Bharat's drug, Covaxin, are underway with about 20,000 volunteers in 26 hospitals, said Suchitra Ella, Bharat's joint managing director, in a televised interview with Rajya Sabha TV on Friday.
He asked Health Minister Harsh Vardhan to clarify. Its use should be avoided till full trials are over.
India's drugs regulator have approved for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech and a state-run institute.
The Subject Expert Committee of Central Drugs Standards Control Organisation had recommended restricted use of Covaxin "in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains".
Police put out new video of woman confronting Black teen
The outlet did not identify the woman aside from her age as "she said she has concerns for her safety unrelated to this incident". Posting the video to Instagram , Mr Harrold recalls that the woman: 'scratched me; she tackled and grabbed him'.
